Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. (Q54347197)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. |
scientific article |
Statements
Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. (English)
1 reference
1 reference
Martha Quezado
1 reference
Katherine J Hahn
1 reference
Nancy Ho
1 reference
Lynne Yockey
1 reference
Samantha Kreuzberg
1 reference
Janine Daub
1 reference
Amy Rump
1 reference
Beatriz E Marciano
1 reference
Steven M Holland
1 reference
Theo Heller
1 reference
Christa S Zerbe
1 reference
1 June 2015
1 reference
110
1 reference
6
1 reference
938-939
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference